Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Successful Establishment of a National Cancer Control Program (NCCP) and Cancer Registry in Eswatini: Lessons to Inform NCCPs in Low- and Mid-Income Countries An observational study following the ...
A new study in the Annals of Surgical Oncology finds that recurrence of intrahepatic cholangiocarinoma after hepatectomy can be 50% to 70%, and about half these recurrences happen within 2 years. The ...
Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial. Effects of regorafenib (REG) therapy on health-related quality ...
"Hepatectomy, including minor and major hepatectomy, may be safe and oncologically feasible in older patients with HCC who have few comorbidities, good liver function reserve, and good performance ...
Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results